clinical trial · NCT04720183
Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
Galapagos NV·phase1·completed·n = 8
HealthySulfasalazineGLPG3970
brief summary
GLPG3970 will be given with sulfasalazine to investigate the effect of co-administration on the pharmacokinetics of sulfasalazine, and on the safety and tolerability of the drugs in healthy adult subjects.
started
Jan 11, 2021
primary completion
Apr 21, 2021
completion
Apr 23, 2021
last updated
Sep 19, 2024
official title
A Phase 1, Fixed Sequence, Open-label, Drug-drug Interaction Study to Evaluate the Effect of GLPG3970 on the Pharmacokinetics of Sulfasalazine in Adult, Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol